Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors


European Commission approves Agamree (vamorolone) to treat Duchenne muscular dystrophy – Santhera Pharma

Written by | 24 Dec 2023

Santhera Pharmaceuticals announces that Agamree (vamorolone) has been approved in the European Union (EU) for the treatment of Duchenne muscular dystrophy (DMD) in patients 4 years of age… read more.

Groundbreaking hip-focused physical therapy reduces low back pain

Written by | 22 Dec 2023

When the University of Delaware’s Gregory Hicks started his research career two decades ago, he was one of only a few people in the United States studying chronic… read more.

New study shows perception of aging is linked to level of physical activity in arthritis patients

Written by | 24 Nov 2023

People with arthritis who report more negative feelings about how they are aging tend to get less physical activity and perceive themselves as less healthy, according to a… read more.

Study finds people with inflammatory arthritis face significant psychological challenges in maintaining employment

Written by | 19 Nov 2023

Research from Hospital for Special Surgery (HSS) reveals a significant psychological impact related to inflammatory arthritis patients’ efforts to maintain employment while coping with the challenges of their… read more.

Study finds hydroxychloroquine lowers risk of nonalcoholic fatty liver disease in rheumatoid arthritis patients

Written by | 11 Nov 2023

New research at ACR Convergence 2023, the American College of Rheumatology’s (ACR) annual meeting, shows that treating rheumatoid arthritis with hydroxychloroquine (HCQ) reduced the risk of nonalcoholic fatty… read more.

Amgen presents new data that show blood decreases for adults treated with Krystexxa (pegloticase)

Written by | 7 Nov 2023

Amgen announced new data for Krystexxa (pegloticase) showing a decrease in blood pressure during treatment of adults living with chronic gout refractory to oral urate-lowering treatment; uncontrolled gout,… read more.

New hope to treat and reverse osteoarthritis

Written by | 5 Nov 2023

Current osteoarthritis treatment manages symptoms rather than addressing the underlying disease, but a new University of Adelaide study has shown the condition may be treatable and reversible. Osteoarthritis… read more.

Common drug can improve hand osteoarthritis symptoms: Study

Written by | 17 Oct 2023

Relief could be on the way for people with painful hand osteoarthritis after a Monash University and Alfred Health-led study found an affordable existing drug can help. Until… read more.

New study reveals the most common form of arthritis, osteoarthritis, affects 15% of the global population over the age of 30

Written by | 26 Aug 2023

A new study projects nearly 1 billion people will be living with osteoarthritis, the most common form of arthritis, by 2050. Currently, 15% of individuals aged 30 and… read more.

Examining when to get off meds for multiple sclerosis

Written by | 2 Aug 2023

Researchers at the Population Health Outcomes and Pharmacoepidemiology Education and Research Center (P-HOPER Center) at the University of Houston College of Pharmacy are examining when older patients with… read more.

Study finds ‘startling’ levels of hidden mental health symptoms among people living with long term autoimmune diseases

Written by | 27 Jul 2023

More than half of patients with auto-immune conditions experience mental health conditions such as depression or anxiety, yet the majority are rarely or never asked in clinic about… read more.

Device for treating challenging bone fractures cleared by FDA

Written by | 26 Jul 2023

A new system for fixing bone fractures, called the Bone Bolt System, has been approved for market by the U.S. Food and Drug Administration (FDA), the University of… read more.

Newsletter Icon

Subscribe for our mailing list

If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.


You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.